Teva Pharmaceutical Indu... Stock Quote TEV - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

16.90

Bid

16.75

Ask

16.90

Volume

14,948

16.85 Day's Range 18.35

0.00 52 Week Range 0.00

Market Cap

19.149B

Previous Close

17.85

Open

17.90

Last Trade

300

16.899999

Last Trade Time

13:36:24

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

1,133,050,214

Dividend Yield

PE Ratio

-37.49

Earnings Per Share (EPS)

-0.49

Revenue

15.85B

Net Profit

-559M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.tevapharm.com

Headquarters

Tel Aviv, Center, Isr

Founded

1901

Teva Pharmaceutical Industries Ltd is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker TEV. The last closing price for Teva Pharmaceutical Indu... was 17.85 €. Over the last year, Teva Pharmaceutical Indu... shares have traded in a share price range of 0.00 € to 0.00 €.

Teva Pharmaceutical Indu... currently has 1,133,050,214 shares outstanding. The market capitalization of Teva Pharmaceutical Indu... is 20.22 € billion. Teva Pharmaceutical Indu... has a price to earnings ratio (PE ratio) of -37.49.

Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth

Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth 2024 Revenues...

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab) REYKJAVIK, Iceland and PARSIPPANY...

Teva annonce un partenariat en vue de commercialiser le candidat biosimilaire de Formycon à Eylea® (aflibercept) dans la majeure partie de l’Europe et en Israël

Teva annonce un partenariat en vue de commercialiser le candidat biosimilaire de Formycon à Eylea® (aflibercept) dans la majeure partie de l’Europe et en Israël Klinge Biopharma GmbH (Klinge...

Teva gibt Zusammenarbeit zur Vermarktung des Formycon Biosimilar-Kandidaten für Eylea® (Aflibercept) in großen Teilen Europas und in Israel bekannt

Teva gibt Zusammenarbeit zur Vermarktung des Formycon Biosimilar-Kandidaten für Eylea® (Aflibercept) in großen Teilen Europas und in Israel bekannt Klinge Biopharma GmbH (Klinge) besitzt die...

Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel

Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel Klinge Biopharma GmbH (Klinge) holds the exclusive...

Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States

Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States Marks a step forward in broadening treatment options for...

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference TEL AVIV, Israel, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced...

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025 TEL AVIV, Israel, Dec. 20, 2024 (GLOBE...

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease

Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease Teva hosting investor call today at 8:00...

Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients

Teva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured Patients Teva to provide two generic inhaler products to Direct Relief for its network of...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

TEV - Frequently Asked Questions (FAQ)

What is the current Teva Pharmaceutical Indu... share price?

The current share price of Teva Pharmaceutical Indu... is 16.90 €

How many Teva Pharmaceutical Indu... shares are in issue?

Teva Pharmaceutical Indu... has 1,133,050,214 shares in issue

What is the market cap of Teva Pharmaceutical Indu...?

The market capitalisation of Teva Pharmaceutical Indu... is EUR 20.22B

What is the 1 year trading range for Teva Pharmaceutical Indu... share price?

Teva Pharmaceutical Indu... has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of Teva Pharmaceutical Indu...?

The price to earnings ratio of Teva Pharmaceutical Indu... is -37.49

What is the cash to sales ratio of Teva Pharmaceutical Indu...?

The cash to sales ratio of Teva Pharmaceutical Indu... is 1.32

What is the reporting currency for Teva Pharmaceutical Indu...?

Teva Pharmaceutical Indu... reports financial results in USD

What is the latest annual turnover for Teva Pharmaceutical Indu...?

The latest annual turnover of Teva Pharmaceutical Indu... is USD 15.85B

What is the latest annual profit for Teva Pharmaceutical Indu...?

The latest annual profit of Teva Pharmaceutical Indu... is USD -559M

What is the registered address of Teva Pharmaceutical Indu...?

The registered address for Teva Pharmaceutical Indu... is 124 DVORA HANEVI’A ST, TEL AVIV, CENTER, 6944020

What is the Teva Pharmaceutical Indu... website address?

The website address for Teva Pharmaceutical Indu... is www.tevapharm.com

Which industry sector does Teva Pharmaceutical Indu... operate in?

Teva Pharmaceutical Indu... operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OUW0Capstone Copper Corp	42.97 € (665.95%)	1.78k
AAHAhlers AG	0.0295 € (84.38%)	67.86k
26A1Argentum Silver Corp	0.0605 € (44.05%)	1.82k
28W0Aston Minerals Limited	0.011 € (37.50%)	354.82k
W47Grid Battery Metals Inc	0.0255 € (34.21%)	5k
4APApollo Minerals Ltd	0.003 € (-62.50%)	17k
RCFTeleperformance SE	42.955 € (-52.93%)	429
E3O1Nexoptic Technology Corp	0.008 € (-46.67%)	8.61k
47GAGo Metals Corp	0.0134 € (-46.40%)	333
7N1GT Resources Inc	0.01 € (-45.95%)	30k
D7GNel ASA	0.2018 € (4.40%)	4.31M
7111BIGG Digital Assets Inc	0.128 € (11.30%)	3.12M
DBKDeutsche Bank AG	19.008 € (-1.54%)	2.17M
3CPXiaomi Corporation	5.119 € (3.08%)	1.22M
G7PAEnergy Transition Minerals Ltd	0.0384 € (-2.54%)	1.11M